• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗环瓜氨酸肽抗体在类风湿关节炎中的价值:它们是否意味着新的危险因素?

The value of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: do they imply new risk factors?

作者信息

López-Longo Francisco Javier, Sánchez-Ramón Silvia, Carreño Luis

机构信息

Department of Rheumatology, University Hospital Gregorio Maranon, Madrid, Spain.

出版信息

Drug News Perspect. 2009 Nov;22(9):543-8. doi: 10.1358/dnp.2009.22.9.1416992.

DOI:10.1358/dnp.2009.22.9.1416992
PMID:20072731
Abstract

Rheumatoid arthritis (RA) is a systemic autoimmune disease that causes chronic inflammation of the joints and several extra-articular manifestations that account for increased morbimortality of these patients. The involvement of B cells in RA pathophysiology was recognized early, with the discovery of rheumatoid factor antibody. Recently, a number of autoantibodies against citrullinated proteins have been described, of which anti-cyclic citrullinated peptide (anti-CCP) is the most specific for RA. A cohort of 937 patients with RA was studied to determine the clinical correlates of anti-CCP antibodies. The presence of anti-CCP antibodies correlated with worse joint involvement and several extra-articular manifestations, i.e., higher incidence of ischemic heart disease independent of classic cardiovascular factors and higher mortality rate. A multivariate logistic regression model showed that only anti-CCP antibodies were independently associated with the development of ischemic heart disease in patients with RA. The clinical value of anti-citrullinated protein antibodies and the relevance of anti-CCP antibodies in daily clinical practice are reviewed.

摘要

类风湿关节炎(RA)是一种全身性自身免疫性疾病,可导致关节慢性炎症以及多种关节外表现,这些表现导致了此类患者更高的病残率和死亡率。随着类风湿因子抗体的发现,B细胞在RA病理生理学中的作用很早就被认识到了。最近,已描述了多种针对瓜氨酸化蛋白的自身抗体,其中抗环瓜氨酸肽(抗CCP)对RA最为特异。对937例RA患者进行了一项队列研究,以确定抗CCP抗体的临床相关性。抗CCP抗体的存在与更严重的关节受累和多种关节外表现相关,即与经典心血管因素无关的缺血性心脏病更高的发病率和更高的死亡率。多变量逻辑回归模型显示,在RA患者中,只有抗CCP抗体与缺血性心脏病的发生独立相关。本文综述了抗瓜氨酸化蛋白抗体的临床价值以及抗CCP抗体在日常临床实践中的相关性。

相似文献

1
The value of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: do they imply new risk factors?抗环瓜氨酸肽抗体在类风湿关节炎中的价值:它们是否意味着新的危险因素?
Drug News Perspect. 2009 Nov;22(9):543-8. doi: 10.1358/dnp.2009.22.9.1416992.
2
Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis.类风湿关节炎患者中抗环瓜氨酸肽抗体与缺血性心脏病之间的关联。
Arthritis Rheum. 2009 Apr 15;61(4):419-24. doi: 10.1002/art.24390.
3
Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.与第二代抗环瓜氨酸肽和类风湿因子相比,抗瓜氨酸化波形蛋白和第三代抗环瓜氨酸肽在预测未分化关节炎和类风湿关节炎疾病转归中的价值。
Arthritis Rheum. 2009 Aug;60(8):2232-41. doi: 10.1002/art.24716.
4
Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations.长期类风湿性关节炎患者的抗环瓜氨酸肽(CCP)抗体及其与关节外表现的关系。
Clin Biochem. 2006 Oct;39(10):961-5. doi: 10.1016/j.clinbiochem.2006.06.004. Epub 2006 Jul 13.
5
Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.抗环瓜氨酸肽抗体对极早期类风湿关节炎的诊断效用
J Rheumatol. 2006 Dec;33(12):2390-7. Epub 2006 Aug 15.
6
The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinated peptide antibodies, and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis.类风湿因子亚型、抗环瓜氨酸肽抗体及抗中性粒细胞胞浆抗体对类风湿关节炎患者死亡率的预测价值。
J Rheumatol. 2005 Nov;32(11):2089-94.
7
Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.抗环瓜氨酸肽抗体可区分慢性乙型肝炎病毒(HBV)感染患者中HBV相关关节病与合并的类风湿关节炎。
J Rheumatol. 2009 Apr;36(4):712-6. doi: 10.3899/jrheum.080653. Epub 2009 Mar 13.
8
The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis.HLA - DRB1共享表位等位基因主要是抗环瓜氨酸肽抗体的一个风险因素,而非类风湿关节炎发病的独立风险因素。
Arthritis Rheum. 2006 Apr;54(4):1117-21. doi: 10.1002/art.21739.
9
Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis?抗环瓜氨酸肽检测对类风湿关节炎的诊断是一项有用的实验室检查吗?
Eur Ann Allergy Clin Immunol. 2004 Apr;36(4):127-30.
10
Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.相比于抗环瓜氨酸肽抗体,抗突变型瓜氨酸波形蛋白抗体在预测早期类风湿关节炎24个月时的疾病活动方面表现更佳。
J Rheumatol. 2008 Jun;35(6):1002-8. Epub 2008 Apr 1.

引用本文的文献

1
Upregulated miR-146b-3p predicted rheumatoid arthritis development and regulated TNF-α-induced excessive proliferation, motility, and inflammation in MH7A cells.上调的 miR-146b-3p 预测类风湿关节炎的发展,并调节 MH7A 细胞中 TNF-α 诱导的过度增殖、迁移和炎症。
BMC Immunol. 2024 Jun 20;25(1):36. doi: 10.1186/s12865-024-00629-9.
2
Rheumatoid Arthritis in Silica-Exposed Workers.硅尘暴露工人的类风湿性关节炎。
Int J Environ Res Public Health. 2021 Dec 3;18(23):12776. doi: 10.3390/ijerph182312776.
3
Laboratory evaluation in rheumatic diseases.
风湿性疾病的实验室评估
World J Methodol. 2017 Mar 26;7(1):1-8. doi: 10.5662/wjm.v7.i1.1.
4
Citrullination in the periodontium--a possible link between periodontitis and rheumatoid arthritis.牙周组织中的瓜氨酸化——牙周炎和类风湿性关节炎之间的可能联系。
Clin Oral Investig. 2016 May;20(4):675-83. doi: 10.1007/s00784-015-1556-7. Epub 2015 Aug 13.
5
Inconsistent treatment with disease-modifying antirheumatic drugs: a longitudinal data analysis.改善病情抗风湿药物治疗的不一致性:一项纵向数据分析
J Rheumatol. 2014 Dec;41(12):2370-8. doi: 10.3899/jrheum.140306. Epub 2014 Oct 15.
6
Do rheumatologists know best? An outcomes study of inconsistent users of disease-modifying anti-rheumatic drugs.风湿病专家是最了解情况的吗?一项关于改变病情抗风湿药使用不规律患者的疗效研究。
Semin Arthritis Rheum. 2015 Feb;44(4):399-404. doi: 10.1016/j.semarthrit.2014.08.003. Epub 2014 Aug 27.
7
Anti-cyclic citrullinated peptide antibodies do not reflect self-reported disability and physical health in patients with rheumatoid arthritis of less than 5 years of duration.抗环瓜氨酸肽抗体并不能反映病程少于 5 年的类风湿关节炎患者的自我报告残疾和身体健康状况。
Rheumatol Int. 2013 Nov;33(11):2763-72. doi: 10.1007/s00296-013-2807-z. Epub 2013 Jun 29.
8
Statins and autoimmunity.他汀类药物与自身免疫。
Immunol Res. 2013 Jul;56(2-3):348-57. doi: 10.1007/s12026-013-8409-8.
9
The influence of ACPA status and characteristics on the course of RA.ACPA 状态和特征对 RA 病程的影响。
Nat Rev Rheumatol. 2012 Jan 31;8(3):144-52. doi: 10.1038/nrrheum.2011.204.
10
Anti-CCP antibodies: the past, the present and the future.抗环瓜氨酸肽抗体:过去、现在和未来。
Nat Rev Rheumatol. 2011 Jun 7;7(7):391-8. doi: 10.1038/nrrheum.2011.76.